98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00425-024-04371-9 | DOI Listing |
Front Oncol
January 2025
New Experimental Therapeutics (NEXT) Oncology, San Antonio, TX, United States.
[This corrects the article DOI: 10.3389/fonc.2024.
View Article and Find Full Text PDFPlanta
March 2024
Molecular Biology and Biotechnology, CSIR-National Botanical Research Institute, Lucknow, 226001, India.
Protein Expr Purif
December 2023
School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, 300072, China. Electronic address:
Proc Natl Acad Sci U S A
May 2020
Department of Molecular Metabolism, Harvard T. H. Chan School of Public Health, Harvard University, Boston, MA 02115;
Numerous mutations that impair retrograde membrane trafficking between endosomes and the Golgi apparatus lead to neurodegenerative diseases. For example, mutations in the endosomal retromer complex are implicated in Alzheimer's and Parkinson's diseases, and mutations of the Golgi-associated retrograde protein (GARP) complex cause progressive cerebello-cerebral atrophy type 2 (PCCA2). However, how these mutations cause neurodegeneration is unknown.
View Article and Find Full Text PDFTraffic
November 2014
Department of Biology, Concordia University, Montreal, Quebec, Canada.
Since the late 1990s, a number of multisubunit tethering complexes (MTCs) have been described that function in membrane trafficking events: TRAPP I, TRAPP II, TRAPP III, COG, HOPS, CORVET, Dsl1, GARP and exocyst. On the basis of structural and sequence similarities, they have been categorized as complexes associated with tethering containing helical rods (CATCHR) (Dsl1, COG, GARP and exocyst) or non-CATCHR (TRAPP I, II and III, HOPS and CORVET) complexes (Yu IM, Hughson FM. Tethering factors as organizers of intracellular vesicular traffic.
View Article and Find Full Text PDF